Skip to main content

Home

Home

Extending the “1+” mechanism for Registration of Pharmaceutical Products containing New Chemical or Biological Entities (Effective on 01.11.2024)

Strengthening the Sales Control of Codeine-containing Products

Regulation of Medical Gases as Pharmaceutical Products

Pharmacy and Poisons Board of Hong Kong, Hong Kong, China Becomes ICH Observer

Be Cautious when Buying Medicines on Internet

Deregistration of Pharmaceutical Products containing Pholcodine

Update of List of Reference Countries for Registration of Pharmaceutical Products (updated on 23.2.2023)

Launch of Electronic Clinical Trial System (e-CTS) on 30 June 2022

List of registered pharmaceutical products indicated for the treatment or prevention of coronavirus disease (COVID-19)

Enhance Regulatory Control of Skin Antiseptic Products

launch of Electronic Certificate of Drug/Product Registration on 1 July 2023

Guidelines and Forms (Update)

Reporting of Adverse Drug Reaction (ADR)

Previous

Pause Play

Next

हिन्दी (Hindi) | नेपाली (Nepali)

اردو (Urdu) | ไทย (Thai)

Bahasa Indonesia | Tagalog

Press Release

Click here link to Press Release

Frequently Asked Question

Click here link to Frequently Asked Question

Search Drug Dealers

Search Drug

Safety Alert




					faq